Vegetative dysfunction in patients with cerebrovascular diseases and metabolic syndrome

Author:
V.N. SHISHKOVA
, Federal State Budgetary Institution National Medical Research Center for Therapeutic and Preventive Medicine, Ministry of Health of the Russian Federation, Moscow, Russia

Place of publication:
NEW THERAPEUTIC JOURNAL "NON NOCERE", MAY 2024

Abstract:
Cerebrovascular diseases (CVD) remain a leading cause of morbidity and disability in most countries today. Metabolic disorders, important risk factors for the development of CVD, are also widespread in the population, regardless of gender and age. The frequent combination of CVD and metabolic disorders, including somatic and abdominal obesity, insulin resistance, hyperinsulinemia, hyperglycemia, and dyslipidemia, provides a springboard for the rapid development of complications. One of the early manifestations of this comorbid association is the development of autonomic dysfunction. Autonomic dysfunction is known to be most often secondary, that is, arising from existing somatic or mental illnesses, but can also develop under the influence of psychogenic factors (stress response, adjustment disorders, psychosomatic illnesses, anxiety and depressive disorders). The most common causes of the development of autonomic dysfunction are organic diseases of the nervous system and somatic diseases, including metabolic and hormonal ones.